Clinical Trials Directory

Trials / Completed

CompletedNCT02084095

IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly

The Role of Insulin-like Growth Factor-I (IGF-I) and Free Fatty Acids in Insulin Resistance, Insulin Secretion and Glucose Metabolism Abnormalities in Acromegaly

Status
Completed
Phase
Study type
Observational
Enrollment
16 (actual)
Sponsor
Carol Davila University of Medicine and Pharmacy · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Background Glucose metabolism abnormalities are frequent in acromegaly. Insulin resistance (IR) correlates with the intensity of acromegaly and Insulin-like Growth factor-I (IGF-I) correlates better with IR than growth hormone (GH). Insulin secretion (IS) is significantly reduced in hyperglycemic acromegalics as compared with those with normal glucose levels. IS is independent of acromegaly intensity. The aim of this study is to show that in active acromegaly: 1) IGF-I does not cause IR but is just a better marker of acromegaly intensity than GH; 2) high GH levels induce IR through free fatty acids (FFA); 3) hyperglycemia is caused by a defficient IS on a background of IR. Methods Intensity of acromegaly will be assessed using serum levels of GH, IGF-I and IGF binding globulin-3. IR and IS will be assessd using an intravenous glucose tolerance test acording to Bergman model. FFA will be directly measured in plasma.

Conditions

Timeline

Start date
2014-03-01
Primary completion
2019-03-01
Completion
2019-03-01
First posted
2014-03-11
Last updated
2019-08-21

Locations

1 site across 1 country: Romania

Source: ClinicalTrials.gov record NCT02084095. Inclusion in this directory is not an endorsement.

IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly (NCT02084095) · Clinical Trials Directory